Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
374.2000 1.80 (0.48%)
NSE Jul 11, 2025 15:31 PM
Volume: 3.1M
 

logo
Biocon Ltd.
02 Nov 2020
374.20
0.48%
Axis Direct
Biocon Ltd is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immune suppressants and anti-diabetic drugs.
Biocon Ltd. has an average target of 389.25 from 4 brokers.
More from Biocon Ltd.
Recommended